One Wealth Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Sell
1,599
-56
-3% -$10.7K 0.04% 240
2026
Q1
$303K Buy
1,655
+51
+3% +$9.4K 0.04% 243
2025
Q4
$282K Buy
+1,604
New +$262K 0.03% 247
2023
Q4
Sell
-809
Closed -$208K 211
2023
Q3
$208K Hold
809
0.05% 179
2023
Q2
$230K Sell
809
-43
-5% -$12.8K 0.05% 183
2023
Q1
$237K Hold
852
0.05% 172
2022
Q4
$236K Buy
+852
New +$241K 0.05% 168
2021
Q4
Sell
-811
Closed -$230K 201
2021
Q3
$230K Sell
811
-263
-24% -$86.2K 0.07% 184
2021
Q2
$372K Sell
1,074
-187
-15% -$56.6K 0.12% 98
2021
Q1
$353K Buy
1,261
+79
+7% +$21.3K 0.14% 90
2020
Q4
$289K Sell
1,182
-93
-7% -$24K 0.16% 89
2020
Q3
$362K Buy
1,275
+283
+29% +$78.9K 0.25% 45
2020
Q2
$265K Buy
992
+291
+42% +$87.5K 0.21% 59
2020
Q1
$222K Buy
+701
New +$213K 0.22% 72
2019
Q2
Sell
-6
Closed -$1K 161
2019
Q1
$1K Buy
+6
New +$1.89K ﹤0.01% 520

Other funds holding BIIB

One Wealth Advisors's BIIB Position: Q2 2026 in Review

One Wealth Advisors reduced its Biogen (BIIB) stake by 3.4% in Q2 2026, selling an estimated $10.7K and leaving 1,599 shares worth $345K. The position accounts for 0.04% of the portfolio, ranked #240.

One Wealth Advisors first reported a position in BIIB in Q1 2019 and has held it in 15 quarters since. The position peaked at $372K in Q2 2021. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • One Wealth Advisors held 1,599 shares of Biogen worth $345K as of Q2 2026.
  • One Wealth Advisors sold 56 Biogen shares in Q2 2026, an estimated $10.7K.
  • Biogen made up 0.04% of One Wealth Advisors's portfolio in Q2 2026, its #240 holding.
  • One Wealth Advisors first reported a position in Biogen in Q1 2019 and has held it in 15 quarters since.
  • One Wealth Advisors's Biogen position peaked at $372K in Q2 2021.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on One Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.